Literature DB >> 25261703

Central auditory processing disorder profile in premature and term infants.

Sanjiv B Amin1, Mark Orlando2, Christy Monczynski2, Kim Tillery3.   

Abstract

OBJECTIVE: The aim of this study is to compare central auditory processing disorder (CAPD) profile between children born prematurely and at term.
METHODS: A retrospective study involving children 7 to 13 years of age who were referred for CAPD evaluation over the past 3 years. Parental reports and medical records were used to collect information. Children with a score ≥ two standard deviations below the mean for at least one ear on at least two different CAPD tests were considered to have CAPD.
RESULTS: A total of 82 children were evaluated for CAPD of which 22 met exclusion criteria, resulting in 60 children with CAPD (15 premature and 45 term). Premature children had higher prevalence of cesarean section delivery and neonatal jaundice compared with term children. Premature children had a higher total number of failed CAPD tests compared with the term children. Among CAPD tests, there was an increased frequency of abnormal Phonemic Synthesis test (PST) and decreased frequency of abnormal Staggered Spondaic Word test (SSW) among premature children compared with term children.
CONCLUSION: Premature children differ in CAPD profile compared with term children. Findings suggest possible etiological differences for CAPD such as jaundice or differential susceptibility of premature children for altered PST and SSW performance when compared with the term children. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 25261703      PMCID: PMC4369183          DOI: 10.1055/s-0034-1387928

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   3.079


  9 in total

Review 1.  Aetiology and clinical presentations of auditory processing disorders--a review.

Authors:  D E Bamiou; F E Musiek; L M Luxon
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

Review 2.  Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.

Authors:  Sanjiv B Amin; Tristram Smith; Hongyue Wang
Journal:  J Autism Dev Disord       Date:  2011-11

Review 3.  Clinical assessment of bilirubin-induced neurotoxicity in premature infants.

Authors:  Sanjiv B Amin
Journal:  Semin Perinatol       Date:  2004-10       Impact factor: 3.300

4.  Auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice.

Authors:  Satish Saluja; Asha Agarwal; Neelam Kler; Sanjiv Amin
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-09-15       Impact factor: 1.675

Review 5.  Childhood auditory processing disorder as a developmental disorder: the case for a multi-professional approach to diagnosis and management.

Authors:  Caroline Witton
Journal:  Int J Audiol       Date:  2010-02       Impact factor: 2.117

6.  Bilirubin and serial auditory brainstem responses in premature infants.

Authors:  S B Amin; C Ahlfors; M S Orlando; L E Dalzell; K S Merle; R Guillet
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

7.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

8.  Hyperbilirubinemia and language delay in premature infants.

Authors:  Sanjiv B Amin; Diane Prinzing; Gary Myers
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

9.  Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population.

Authors:  C E Ahlfors; S B Amin; A E Parker
Journal:  J Perinatol       Date:  2009-02-26       Impact factor: 2.521

  9 in total
  2 in total

Review 1.  Bilirubin Binding Capacity in the Preterm Neonate.

Authors:  Sanjiv B Amin
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

Review 2.  Development of Auditory Cortex Circuits.

Authors:  Minzi Chang; Patrick O Kanold
Journal:  J Assoc Res Otolaryngol       Date:  2021-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.